Jun 07,2023

Dario Announces Two New Full Suite Employer Contracts

DarioHealth Corp. has announced two new employer contracts for their integrated solutions. The contracts, scheduled to launch in the second half of 2023, involve an educational organization in Tennessee and a non-profit in the New York metropolitan area. Both new accounts selected Dario for the ease of a single, integrated solution to provide employees with a more holistic approach to chronic condition management and to reduce administrative burdens and cost for the employer.

PRODUCT

#coaching

View Analyst & Ambassador Comments
Go to original news
Mar 22,2023

Dario Announces Strategic Partnership with Amwell to Expand Access to its Cardiometabolic Digital Therapeutic Solution

DarioHealth Corp. has announced a strategic partnership with Amwell, a digital healthcare enablement leader, to deliver its cardiometabolic digital therapeutic solution to Amwell customers starting in the second half of 2023. The partnership aims to accelerate the adoption of Dario's solutions by making its proven and highly personalized digital solution available to Amwell's comprehensive portfolio of care solutions and affiliated clinicians. Members living with cardiometabolic health concerns such as diabetes, high blood pressure, and weight management challenges will have access to Dario's digital solution to better manage their conditions and improve outcomes between visits with clinicians practicing on the Amwell platform

COLLABORATION PARTNERSHIP

#institution

#telehealth

#mobile app

View Analyst & Ambassador Comments
Go to original news
Jun 07,2023 TOP STORY

Dario Announces Two New Full Suite Employer Contracts

DarioHealth Corp. announced today two new employer contracts for the Company's full suite of integrated solutions. The new accounts are scheduled to launch in the second half of 2023, involve an educational organization in Tennessee and a non-profit in the New York metropolitan area. Both new accounts selected Dario for the ease of a single, integrated solution to provide employees with a more holistic approach to chronic condition management and to reduce administrative burdens and cost for the employer.

PRODUCT

#coaching

View Analyst & Ambassador Comments
Go to original news
May 09,2023

Sanofi research demonstrates 9.3% reduction in all-cause healthcare resource utilization rates, including 23.5% decrease in hospitalization for Dario users

DarioHealth announced today the presentation of research at ISPOR 2023 demonstrating significant reductions in healthcare resource utilization for Dario users with type 2 diabetes compared to non-users, the first study completed by Sanofi U.S. under its strategic agreement with Dario. This study used de-identified user data from Dario and claims data, through tokenization, to build highly comparable groups through a meticulous matching method that matched 2,445 Dario users with 7,334 non-users. The difference-in-difference method was used to analyze changes between the start and end of the study period in each group and between Dario user and non-user groups, on predefined primary and secondary endpoints. The results demonstrate a statistically significant 9.3% reduction in all-cause Heath Care Resource Utilization (HCRU), including a 23.5% reduction in hospitalizations, in Dario users after 12 months.

CLINICAL STUDY

#dtx

View Analyst & Ambassador Comments
Go to original news
Apr 18,2023

Teladoc Health Launches Provider-Based Care for Weight Management & Prediabetes Programs

Teladoc Health announced the expansion of Provider-Based Care for weight management and prediabetes programs, besides the currently available programs for diabetes and hypertension. Provider-Based Care delivers an integrated care experience for members, including access to a Teladoc Health physician for a personalized care plan, along with coaching for day-to-day guidance with actionable digital tools. These Teladoc Health solutions are designed to help members lose weight as well as prevent and manage diabetes by safely optimizing medications, such as Glucagon-like peptide (GLP-1) agonists and Sodium-glucose cotransporter-2 (SGLT2) inhibitors, and work in conjunction with the range of Teladoc Health solutions and tools that address the foundational pillars impacting cardiometabolic health. Provider-Based Care became available for diabetes and hypertension solutions nationwide in early 2023. The expansion of this service to weight management and prediabetes will be available in Q3 2023.

PRODUCT

#virtual care

#telehealth

#coaching

View Analyst & Ambassador Comments
Go to original news
Apr 03,2023

Wellth raises $20M for health app with financial rewards

Wellth, a digital health startup that offers small financial rewards for completing health-related tasks, scooped up $20 million in Series B funding. Wellth works with insurers, providers and employers to offer an app that reminds users about daily health behaviors, like taking medications or monitoring blood glucose. When patients take a photo confirming they've completed tasks, they receive small financial incentives. The company includes services for mental health concerns, cardiovascular disease, heart failure, diabetes, cancer, chronic kidney disease and COPD or asthma.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Mar 27,2023

Philips unveils new Virtual Care Management portfolio

Philips announced today that it debuted its Philips Virtual Care Management portfolio of flexible solutions and services. The Amsterdam-based medtech giant aims to help health systems, providers, payers and employers connect with patients from virtually anywhere. It designed the portfolio to reduce pressure on hospital staff by decreasing emergency department visits and reducing care costs by better managing chronic care. Philips Virtual Care Management’s condition-specific protocols now include diabetes, hypertension, chronic kidney disease, chronic obstructive pulmonary disease (COPD) and heart disease. These protocols combine with connected devices and engagement tools on a secure, interoperable cloud-based platform. Licensed clinical professionals offer monitoring and personalized coaching, while Philips brings expert-led professional services. Philips said its virtual care program “goes beyond traditional remote patient management.” It features scalable solutions and services to foster patient engagement and empower healthier behaviors.

PRODUCT

#virtual care

#rpm

View Analyst & Ambassador Comments
Go to original news
Mar 27,2023

Dario Selected as Digital Therapeutics Partner by a Top-Ten Digitally Enabled Pharmacy Benefits Manager

DarioHealth announced a new contract with a leading nationwide Pharmacy Benefits Manager operating in 50 states to provide Dario's digital therapeutics, starting with the diabetes solution, to employer clients beginning in the second quarter of 2023. Through the new contract, the PBM will replace an existing digital diabetes solution with Dario's cardio metabolic digital therapeutic. Members who are currently users of the PBM's digital diabetes offering will be transitioned to Dario upon launch, which is expected to generate revenue in the second quarter and grow significantly through the rest of 2023. The agreement is the first contract to originate through Dario's previously announced strategic partnership with Sanofi U.S., representing a milestone achievement one year into the agreement.

COLLABORATION PARTNERSHIP

#institution

#dtx

View Analyst & Ambassador Comments
Go to original news
Mar 27,2023

New Study from Teladoc Health Further Validates the Effectiveness of a Single, Integrated Care Experience

Teladoc Health, the global leader in whole-person virtual care, today released new findings from a peer-reviewed study showing individual improvements in A1c, systolic blood pressure and weight, when enrolled in multiple chronic condition management programs over time. Individuals participating only in a diabetes program with a self-reported A1c greater than 7% who then engaged with hypertension, weight management and mental health programs saw an additional reduction in A1c (0.44%). Individuals starting on the weight management program with a BMI greater or equal to 30 who then engaged in three programs, saw an additional 1.0% reduction in body weight.

CLINICAL STUDY

#virtual care

View Analyst & Ambassador Comments
Go to original news
Mar 23,2023

Welldoc Earns 2023 BIG Artificial Intelligence Excellence Award

Welldoc has been named an Artificial Intelligence Excellence Award winner for its chronic care platform that integrates personalized, actionable insights into the daily lives of individuals living with chronic conditions and comorbidities. The scalable platform provides AI-driven digital coaching focused on total health across diabetes, pre-diabetes, hypertension, heart failure, weight management and includes mental well-being guidance, which is an essential aspect of holistic chronic care.

PRODUCT

#coaching

View Analyst & Ambassador Comments
Go to original news
Subscribe to HYPERTENSION